Comparing cardiovascular risk factors in older persons with mild cognitive impairment and lifetime history of major depressive disorder.
Alzheimer’s disease
affective symptoms
cardiovascular diseases
cognitive dysfunction
dementia
major depressive disorder
mild cognitive impairment
vascular risk factors
Journal
International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
pubmed:
30
3
2021
medline:
29
6
2022
entrez:
29
3
2021
Statut:
ppublish
Résumé
To compare the prevalence of select cardiovascular risk factors (CVRFs) in patients with mild cognitive impairment (MCI) versus lifetime history of major depression disorder (MDD) and a normal comparison group using baseline data from the Prevention of Alzheimer's Dementia with Cognitive Remediation plus Transcranial Direct Current Stimulation (PACt-MD) study. Baseline data from a multi-centered intervention study of older adults with MCI, history of MDD, or combined MCI and history of MDD (PACt-MD) were analyzed. Community-based multi-centered study based in Toronto across 5 academic sites. Older adults with MCI, history of MDD, or combined MCI and history of MDD and healthy controls. We examined the baseline distribution of smoking, hypertension and diabetes in three groups of participants aged 60+ years in the PACt-MD cohort study: MCI (n = 278), MDD (n = 95), and healthy older controls (n = 81). Generalized linear models were fitted to study the effect of CVRFs on MCI and MDD as well as neuropsychological composite scores. A higher odds of hypertension among the MCI cohort compared to healthy controls (p < .05) was noted in unadjusted analysis. Statistical significance level was lost on adjusting for age, sex and education (p > .05). A history of hypertension was associated with lower performance in composite executive function (p < .05) and overall composite neuropsychological test score (p < .05) among a pooled cohort with MCI or MDD. This study reinforces the importance of treating modifiable CVRFs, specifically hypertension, as a means of mitigating cognitive decline in patients with at-risk cognitive conditions.
Identifiants
pubmed: 33775259
pii: S1041610221000259
doi: 10.1017/S1041610221000259
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
563-569Commentaires et corrections
Type : CommentIn